MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 181 filers reported holding MERIDIAN BIOSCIENCE INC in Q4 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,229,800 | +157.3% | 37,031 | +144.2% | 0.00% | – |
| Q3 2022 | $478,000 | +45.3% | 15,162 | +40.2% | 0.00% | – |
| Q2 2022 | $329,000 | -86.1% | 10,812 | -88.1% | 0.00% | -100.0% |
| Q1 2022 | $2,360,000 | +46.6% | 90,902 | +15.2% | 0.00% | – |
| Q4 2021 | $1,610,000 | -20.4% | 78,900 | -24.9% | 0.00% | -100.0% |
| Q3 2021 | $2,022,000 | -11.7% | 105,100 | +1.8% | 0.00% | – |
| Q2 2021 | $2,290,000 | +51.9% | 103,223 | +79.7% | 0.00% | – |
| Q1 2021 | $1,508,000 | +681.3% | 57,453 | +457.8% | 0.00% | – |
| Q4 2020 | $193,000 | -46.8% | 10,300 | -51.9% | 0.00% | – |
| Q3 2020 | $363,000 | -64.1% | 21,394 | -50.7% | 0.00% | -100.0% |
| Q2 2020 | $1,011,000 | +592.5% | 43,389 | +148.9% | 0.00% | – |
| Q1 2020 | $146,000 | +4.3% | 17,432 | +74.1% | 0.00% | – |
| Q4 2017 | $140,000 | – | 10,011 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYQUANT CAPITAL SAS | 134,804 | $4,477 | 11.01% |
| Vazirani Asset Management LLC | 115,774 | $3,845 | 6.51% |
| FIFTH LANE CAPITAL, LP | 185,914 | $6,174,204 | 5.56% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 1,939,075 | $64,396,681 | 5.01% |
| Crystalline Management Inc. | 244,453 | $8,118,284 | 4.08% |
| FNY Investment Advisers, LLC | 51,000 | $1,693 | 2.36% |
| HAVENS ADVISORS LLC | 26,800 | $890,028 | 2.26% |
| Euclidean Technologies Management, LLC | 62,995 | $2,092,064 | 1.99% |
| Sand Grove Capital Management LLP | 537,060 | $17,836 | 1.70% |
| Crabel Capital Management, LLC | 120,337 | $3,996 | 1.45% |